Franklin Resources
STML

Franklin Resources’s Stemline Therapeutics, Inc. STML Stock Holding History

Franklin Resources’s Portfolio STML Stock Details STML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,449,073
Closed -$12.4M – 1548
2017
Q1 		$12.4M Hold
1,449,073
– – 0.01% 913
2016
Q4 		$15.5M Sell
1,449,073
-193,124
-12% -$2.34M 0.01% 860
2016
Q3 		$17.8M Sell
1,642,197
-460,003
-22% -$3.74M 0.01% 840
2016
Q2 		$14.2M Buy
2,102,200
+222,170
+12% +$1.4M 0.01% 895
2016
Q1 		$8.76M Buy
1,880,030
+270,700
+17% +$1.32M ﹤0.01% 1009
2015
Q4 		$10.2M Buy
1,609,330
+50,800
+3% +$412K 0.01% 1001
2015
Q3 		$13.8M Hold
1,558,530
– – 0.01% 939
2015
Q2 		$18.3M Buy
1,558,530
+236,800
+18% +$3.29M 0.01% 904
2015
Q1 		$19.1M Buy
1,321,730
+350,000
+36% +$5.36M 0.01% 907
2014
Q4 		$16.6M Hold
971,730
– – 0.01% 933
2014
Q3 		$12.1M Sell
971,730
-190,800
-16% -$2.35M 0.01% 1015
2014
Q2 		$17.1M Buy
1,162,530
+10,182
+0.9% +$156K 0.01% 919
2014
Q1 		$23.5M Buy
1,152,348
+371,348
+48% +$9.01M 0.01% 814
2013
Q4 		$15.3M Buy
781,000
+361,300
+86% +$9.64M 0.01% 893
2013
Q3 		$19M Buy
419,700
+156,500
+59% +$5.1M 0.01% 821
2013
Q2 		$6.28M Buy
+263,200
New +$4.19M ﹤0.01% 1035

Other funds holding STML

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
IBT
International Biotechnology Trust London, United Kingdom $297M AUM 17.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Franklin Resources's STML Position: Q2 2017 in Review

Franklin Resources sold out of Stemline Therapeutics, Inc. (STML) in Q2 2017, closing a stake of 1,449,073 shares — an estimated $12.4M sold.

Franklin Resources first reported a position in STML in Q2 2013 and held it in 16 quarters. The position peaked at $23.5M in Q1 2014. 70 funds tracked by Wall St. Rank hold STML as of Q2 2017.

  • Franklin Resources reported no remaining Stemline Therapeutics, Inc. position as of Q2 2017 after selling out during the quarter.
  • Franklin Resources sold 1,449,073 Stemline Therapeutics, Inc. shares in Q2 2017, an estimated $12.4M.
  • Franklin Resources first reported a position in Stemline Therapeutics, Inc. in Q2 2013 and held it in 16 quarters.
  • Franklin Resources's Stemline Therapeutics, Inc. position peaked at $23.5M in Q1 2014.
  • 70 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q2 2017.

Based on Franklin Resources's 13F filing for Q2 2017, filed 10 Aug 2017.